Overview

Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations

Status:
Completed
Trial end date:
1998-09-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine the safety and efficacy of inhaled and subcutaneously administered heparin in the treatment of hereditary angioedema.
Phase:
N/A
Details
Lead Sponsor:
University of Iowa
Treatments:
Calcium heparin
Heparin